Plain-English translation of NCT07064798 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether a device called the Paxman Limb Cryocompression System โ which cools and gently compresses your arms and legs โ can help prevent a common side effect of taxane chemotherapy called peripheral neuropathy. Peripheral neuropathy is nerve damage that causes numbness, tingling, pain, or weakness in your hands and feet. Some early research suggests that cooling therapy may protect nerves during chemotherapy, and this study will see whether this approach really works and is safe.
Many people receiving taxane chemotherapy develop peripheral neuropathy, which can be painful and long-lasting, and there are limited ways to prevent it. This trial exists to find out whether this treatment can reduce that risk and improve quality of life for cancer patients.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you enroll, you'll have about a 2 in 3 chance of receiving the cooling device along with your regular chemotherapy, or a 1 in 3 chance of receiving chemotherapy alone (the standard approach). Either way, you'll visit the clinic for your regular chemotherapy sessions and complete questionnaires at the start, during treatment, and at the end to help researchers track any nerve damage or side effects. The study involves about 50 people total.
AI-generated summary from trial data ยท Jun 1, 2026 ยท Not medical advice
United States